Salt-Wasting Congenital Adrenal Hyperplasia: Detection of Mutations in CYP21B Gene in a Chilean Population1
Carlos E. Fardella,
Helena Poggi,
Pedro Pineda,
Julia Soto,
Isabel Torrealba,
AndreÍna Cattani,
Eveline Oestreicher and
Arnaldo Foradori
Department of Endocrinology (C.E.F., A.C., E.O.) and The Research
and Development Unit of the Associated Unit of Clinical Laboratories
(H.P., J.S., A.F.), Faculty of Medicine, Catholic University of Chile;
and Department of Endocrinology of the Clinical Hospital at University
of Chile (P.P.), Endocrinology Service (I.T.), Sotero del Rio and Luis
Calvo Mackenna Hospitals, Public Health Services, Santiago, Chile
Address all correspondence and requests for reprints to: Carlos E. Fardella, Department of Endocrinology, Pontificia Universidad Catolica de Chile, Lira 44, Santiago, Chile.
The steroid 21-hydroxylase deficiency (21OHD) is the most frequent
causeof congenital adrenal hyperplasia. We have characterized the
disease-causingmutations in the 21-hydroxylase genes of 63 patients
with salt-wastingcongenital adrenal hyperplasia from a Chilean
population ofHispanic origin, a group that has been scarcely
evaluated. Usingallele-specific PCR, lesions were identified in 97
chromosomesout of 126 tested (77%). The most frequent findings were
thegene deletion or large gene conversion (LGC) = 22.9%, I2
splice= 19%, R357W = 12.7%, and Q319X = 10.5%. We
did not find alleleswith the mutation F308insT and we found three
alleles with thecluster E6. The frequency of the point mutation R357W
was atleast two times more frequent than the one found in Caucasians
populations,but similar to that communicated in Asian populations;
thisfinding may be explained by the Asian ancestry of our
South-Amerindianpopulation. The frequency of Q319X was also high,
similar onlyto those patients studied in Italy and in a neighboring
Argentinianpopulation. In summary, this is a genetic characterization
of21OHD made in an almost pure Hispanic population in Latin America.
Thehigh frequency of deletion of CYP21B gene, I2 splice, R357W,and
Q319X mutations probably reflects the European-Caucasian-Spanish
influenceof the conquerors, mixed with Amerindians of Asian ancestry
andmodulated by other European immigrations.
This article has been cited by other articles:
A. Martinez-Aguayo, A. Rocha, N. Rojas, C. Garcia, R. Parra, M. Lagos, L. Valdivia, H. Poggi, A. Cattani, and the Chilean Collaborative Testicular Adrenal Rest Testicular Adrenal Rest Tumors and Leydig and Sertoli Cell Function in Boys with Classical Congenital Adrenal Hyperplasia
J. Clin. Endocrinol. Metab.,
December 1, 2007;
92(12):
4583 - 4589.
[Abstract][Full Text][PDF]
F. Votava, D. Torok, J. Kovacs, D. Moslinger, S. M Baumgartner-Parzer, J. Solyom, Z. Pribilincova, T. Battelino, J. Lebl, H. Frisch, et al. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia
Eur. J. Endocrinol.,
June 1, 2005;
152(6):
869 - 874.
[Abstract][Full Text][PDF]
M. Kharrat, V. Tardy, R. M'Rad, F. Maazoul, L. B. Jemaa, M. Refai, Y. Morel, and H. Chaabouni Molecular Genetic Analysis of Tunisian Patients with a Classic Form of 21-Hydroxylase Deficiency: Identification of Four Novel Mutations and High Prevalence of Q318X Mutation
J. Clin. Endocrinol. Metab.,
January 1, 2004;
89(1):
368 - 374.
[Abstract][Full Text][PDF]
J. Kovacs, F. Votava, G. Heinze, J. Solyom, J. Lebl, Z. Pribilincova, H. Frisch, T. Battelino, and F. Waldhauser Lessons From 30 Years of Clinical Diagnosis and Treatment of Congenital Adrenal Hyperplasia in Five Middle European Countries
J. Clin. Endocrinol. Metab.,
July 1, 2001;
86(7):
2958 - 2964.
[Abstract][Full Text][PDF]
M. Dracopoulou-Vabouli, M. Maniati-Christidi, and C. Dacou-Voutetakis The Spectrum of Molecular Defects of the CYP21 Gene in the Hellenic Population: Variable Concordance between Genotype and Phenotype in the Different Forms of Congenital Adrenal Hyperplasia
J. Clin. Endocrinol. Metab.,
June 1, 2001;
86(6):
2845 - 2848.
[Abstract][Full Text][PDF]
P. C. White and P. W. Speiser Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Endocr. Rev.,
June 1, 2000;
21(3):
245 - 291.
[Abstract][Full Text]
H.-H. Lee, J.-G. Chang, C.-H. Tsai, F.-J. Tsai, H.-T. Chao, and B.-c. Chung Analysis of the Chimeric CYP21P/CYP21 Gene in Steroid 21-Hydroxylase Deficiency
Clin. Chem.,
May 1, 2000;
46(5):
606 - 611.
[Abstract][Full Text][PDF]
C. Fardella, P. Zamorano, L. Mosso, L. Gomez, M. Pinto, J. Soto, E. Oestreicher, P. Cortes, X. Claverie, and J. Montero A-6G Variant of Angiotensinogen Gene and Aldosterone Levels in Hypertensives
Hypertension,
October 1, 1999;
34(4):
779 - 781.
[Abstract][Full Text][PDF]